Welcome to our dedicated page for Jack Nathan Med news (Ticker: JNHMF), a resource for investors and traders seeking the latest updates and insights on Jack Nathan Med stock.
Jack Nathan Medical Corp. reports corporate and operating developments tied to its transition from a retail medical clinic network to a Canadian MedSpa-focused business. The company, also known as Jack Nathan Health, operates MedSpa clinics in Canada and has exited its Canadian primary care and licensee business and its Walmart Mexico clinic operations.
Recurring news themes include IFRS financial results, restructuring actions, balance sheet optimization, discontinued operations, leadership changes, and strategic reviews. Updates also cover the capital structure effects of legacy financing arrangements and the company's efforts to stabilize operations after divestitures and clinic closures.
Jack Nathan Medical Corp (TSXV: JNH; Pink: JNHMF) announced a leadership transition on January 23, 2026. Mike Marchelletta is stepping down as CEO and vice-chairman to lead a prospective investor syndicate evaluating a potential strategic transaction; there is no assurance a transaction will complete. Michael Di Cesare, co-founder and former COO, is appointed Interim CEO and vice-chairman to provide operational continuity. Mr. Marchelletta agreed to a four-month lock-up on 21,000,000 common shares, temporary assignment of those voting rights to Mr. Di Cesare as trustee, ongoing voting support, and voluntary deferral of executive compensation. The company said it eliminated approximately $15 million of debt and cancelled about 140 million common shares previously issuable under legacy debenture arrangements.
Jack Nathan Health (OTCID: JNHMF) reported Q2 fiscal 2026 financial results, marking significant operational changes. The company announced the complete closure of its Mexico operations following termination of its Walmart Mexico agreement, shifting focus entirely to its Canadian MedSpa business.
Q2 financial highlights include revenue of $227,532, down from $264,546 in Q2 2024. Six-month revenue reached $412,791, a 14% decrease from the previous year's $471,548. Operating expenses improved to $709,698 from $1,088,630 year-over-year. The company maintains $0.80 million in cash and operates four MedSpa clinics across Alberta and Ontario.
Management expects to reach breakeven by year-end through cost restructuring and a leaner business model focused on Canadian operations.
Jack Nathan Health (OTCQB: JNHMF) reported its Q1 fiscal 2026 financial results, marking a transitional period following significant corporate restructuring. The company posted revenues of $1.99 million, down 4% year-over-year, with MedSpa revenues at $185,259 representing 9% of total revenue.
The company reported a loss from operations of $830,959, compared to $684,936 in the prior year. As of April 30, 2025, Jack Nathan Health maintained cash reserves of $0.91 million, down from $2.2 million in January 2025, with total assets of $2.65 million and total liabilities of $2.45 million.
Notably, the company has completely ceased operations in Mexico as of June 30, 2025, following the termination of its Walmart Mexico agreement, and is now focusing on building its MedSpa platform in Canada after divesting its Canadian medical clinic and licensee business in December 2024.
Jack Nathan Health (OTCQB: JNHMF) has released its Q4 and fiscal year 2025 financial results, marking a significant transitional period. The company reported total consolidated revenues of $19.1 million, with continuing operations revenue increasing 26% to $8.7 million. Notable highlights include MedSpa revenue growth of 90% year-over-year to $1.03 million.
The company completed two major strategic exits: the divestiture of its Canadian primary care and licensee business, resulting in a $16.4 million gain, and the cessation of Mexico operations as of June 30, 2025. The company's balance sheet shows cash of $2.2 million and improved working capital of $1.4 million, compared to a previous deficit of $0.5 million.
Jack Nathan Medical Corp (TSXV: JNH; OTCQB: JNHMF) announces critical developments regarding its Mexico operations. The company has been unable to reach an agreement with Walmart Mexico for business continuity of its 171 healthcare facilities within Walmart Mexico stores and distribution centres.
Following unsuccessful negotiations, Walmart Mexico has issued termination notices, with operations expected to cease by May 31, 2025. The company is actively exploring strategic alternatives, including:
- Selling Mexico operations to a successor
- Establishing partnerships with new retail and corporate entities
- Potential mergers and acquisitions
A comprehensive data room will be available to qualified interested parties. Without securing a new agreement or M&A transaction, JNH faces a potential wind-down of its Mexican operations.
Jack Nathan Medical Corp (TSXV: JNH; OTCQB: JNHMF) announces strategic evaluation of its Mexico operations due to challenges with Walmart Mexico partnership. The company is exploring multiple options for its 171 facilities within Walmart Mexico stores including:
- Potential sale to a successor or competing medical operator
- Renegotiation of business terms with Walmart Mexico
- Development of a bilateral transition plan
While the company has secured a profit-sharing agreement with Walmart Canada effective December 1, 2024, failure to reach an agreement in Mexico could lead to a potential wind-down of Mexican operations. The company is also exploring partnerships with other retail and corporate entities as alternatives. A comprehensive data room will be available to qualified interested parties for due diligence.
Jack Nathan Health (JNHMF) reported Q3 fiscal 2025 results with revenue growth of 16% year-to-date, reaching $15.9M compared to $13.7M in 2023. The company's Mexican operations, which added 7 new clinics during Q3 bringing the total to 168 corporate-owned clinics, drove this growth. Clinic operations generated 89% of total revenues at $4.7M for Q3.
The company reported an operating loss of $4.5M for the nine months ended October 31, 2024, up from $3.8M in 2023. Post-quarter, the company completed the sale of its Canadian operations to WELL Health Technologies for $5M, resulting in the elimination of over $15M in debt owed to Wal-Mart Canada Corp. The company now focuses on Mexican operations and MedSpa sector expansion.
Jack Nathan Health has completed the sale of its Canadian business to WELL Health Technologies for Cdn$5,000,000. The transaction eliminates over Cdn$15 million in debt owed to Wal-Mart Canada Corp. The company retains its Mexican operations, including 155 corporate-owned clinics in Walmart locations, five clinics in Walmart distribution centers, and one multidisciplinary clinic. The deal includes a profit-sharing agreement with Walmart, granting them 10% interest in the first year and 25% thereafter until Cdn$4 million is paid. Following the transaction, Dr. Glenn Copeland and Marcy Herriman have stepped down from their executive positions, with Mike Marchelletta assuming the role of CEO.
Jack Nathan Medical Corp. (TSXV: JNH; OTCQB: JNHMF) has agreed to sell its Canadian business to WELL Health Technologies for Cdn$5,000,000 in cash. The deal includes the extinguishment of over Cdn$15,000,000 debt owed to Wal-Mart Canada. Post-transaction, the company will retain its Mexican operations, including 155 Walmart-based clinics, 5 distribution center clinics, and 1 multidisciplinary clinic. WELL is providing an interim credit facility of up to $750,000 at 12% interest. The deal requires shareholder approval, with 24.36% of shareholders already committed. As part of the agreement, JN Mexico will share 10% of profits in year one and 25% thereafter with Walmart, until Cdn$4 million is paid.